‘Cellicon’ Valley? Philadelphia has the capabilities to advance cell and gene therapies, says exec

Pennsylvaniaâs capital has the logistics, capabilities, and expertise required to advance next-generation therapies in the US, says industry expert.

More From BioPortfolio on "‘Cellicon’ Valley? Philadelphia has the capabilities to advance cell and gene therapies, says exec"